Form 4: Madrigal Director Sells Shares for Tax Obligations

Madrigal Pharmaceuticals Director Rebecca Taub sold 491 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

Summary

• Rebecca Taub, a Director of Madrigal Pharmaceuticals, Inc. (MDGL), sold 491 shares of common stock.
• The sale occurred on March 6, 2026, at a price of $431.94 per share.
• This transaction was an automatic sale by the Issuer on behalf of Ms. Taub to cover tax withholding obligations associated with the vesting of restricted stock units.
• The sale was not at the discretion of the Reporting Person.
• Following the transaction, Ms. Taub directly owns 452,213 shares and indirectly owns 655,540 shares through SQN LLC.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it is a routine, non-discretionary sale to cover tax obligations from RSU vesting, not indicative of a change in management's outlook.

Positives

• The sale was automatic and not discretionary, indicating it was not a voluntary divestment based on a negative outlook.
• The transaction is a result of restricted stock unit vesting, which implies compensation for the director.

Negatives

• A reduction in direct beneficial ownership by 491 shares.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that sales of shares to cover tax withholding obligations upon the vesting of restricted stock units are a common and routine occurrence for corporate insiders, reflecting a standard compensation practice rather than a discretionary investment decision.

Comparison to Industry Standards

• This type of transaction is standard practice across publicly traded companies globally when restricted stock units vest, as it allows the recipient to meet immediate tax liabilities without needing to use personal funds.
• Comparable companies like Pfizer (PFE) or Merck (MRK) frequently report similar tax-related sales by their executives and directors.
• The volume of shares sold (491) is relatively small compared to the total beneficial ownership, aligning with typical tax-related sales percentages.

Related Party Transactions

• Rebecca Taub and her spouse are managing members of SQN, LLC, which indirectly holds 655,540 shares of Madrigal Pharmaceuticals common stock.

Stakeholder Impact

• Minimal impact on shareholders, as this is a small, non-discretionary sale for tax purposes.
• No direct impact on employees, customers, suppliers, or creditors.

Key Dates

Recommendation

This Form 4 filing details a routine, non-discretionary sale of shares by a director to cover tax obligations associated with restricted stock unit vesting. Such transactions are common and generally do not signal a change in the company's fundamentals or the insider's confidence. Therefore, it provides no new information that would warrant a change in investment recommendation, suggesting a 'hold' position is appropriate based solely on this filing.

Keywords

Madrigal Pharmaceuticals, MDGL, Rebecca Taub, Form 4, Insider Trading, Stock Sale, Restricted Stock Units, Tax Withholding, Director